A break in the brake mechanism in diabetes a cause of postprandial hyperglycemia

Diabetes Care

Volumn 31, Issue 12, 2008, Pages 2410-2413

  Vinik, Aaron ^a   Nakave, Archana ^a   Chuecos, Maria Del Pilar Silva ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; EXENDIN 4; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HUMAN ISLET AMYLOID PANCREATIC PEPTIDE; NITRIC OXIDE; PEPTIDE; PRAMLINTIDE; UNCLASSIFIED DRUG;

AREA POSTREMA; BEZOAR; CHOLINERGIC ACTIVITY; DEFENSE MECHANISM; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; GASTROINTESTINAL SYMPTOM; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOGLYCEMIA; HYPOTHALAMUS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN LIKE ACTIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CELL; PEPTIDERGIC NERVOUS SYSTEM; POSTPRANDIAL STATE; PROTEIN DEFICIENCY; REVIEW; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH PARESIS; VAGUS NERVE STIMULATION;

BLOOD GLUCOSE; DIABETES MELLITUS; GASTRIC EMPTYING; HUMANS; HYPERGLYCEMIA; POSTPRANDIAL PERIOD;

EID: 64349089142     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1694     Document Type: Review

References (35)

1. Woerle HJ, Szoke E, Meyer C, Dostou JM, Wittlin SD, Gosmanov NR, Welle SL, Gerich JE: Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 290:E67-E77, 2006
2. FrankJW, Saslow SB, Camilleri M, Thom- forde GM, Dinneen S, Rizza RA: Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 109:755-765, 1995
3. Stacher G: Diabetes and the stomach. Dig Liver Dis 32 (Suppl. 3):S253-S254, 2000
4. Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M: Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 19:177-194, 2002
5. Camilleri M: Clinical practice. Diabetic gastroparesis. N Engl J Med 356:820-829, 2007
6. Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J: Hypergly- caemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33:675-680, 1990
7. Woerle HJ, Albrecht M, Linke R, Zschau S, Neumann C, Nicolaus M, Gerich J, Goke B, Schirra J: Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans. Am J Physiol Endocrinol Metab 294:E103-E109, 2008
8. Schvarcz E, Palmer M, Aman J, Horowitz M, Stridsberg M, Berne C: Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin- dependent diabetes mellitus. Gastroenterology 113:60 -66, 1997
9. Kuo P, Rayner CK, Horowitz M: Gastric emptying, diabetes, and aging. Clin Geriatr Med 23:785-808 2007
10. Chaikomin R, Rayner CK, Jones KL, Horowitz M: Upper gastrointestinal function and glycemic control in diabetes mel- litus. World J Gastroenterol 12:5611-5621, 2006
11. GautierJF, Choukem SP, Girard J: Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes. Diabetes Metab 34 (Suppl 2):S65-S72, 2008
12. SchirraJ, NicolausM, RoggelR, Katschinski M, Storr M, Woerle HJ, Goke B: Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro- pyloro-duodenal motility in humans. Gut 55:243-251, 2006
13. Young A: Inhibition of gastric emptying. Adv Pharmacol 52:99-121, 2005
14. Patil CS, Singh VP, Jain NK, Kulkarni SK:Inhibitory effect of sildenafil on gastrointestinal smooth muscle: role of NO-cGMP transduction pathway. Indian J Exp Biol 43:167-171,2005
15. Orihata M, Sarna SK: Inhibition of nitric oxide synthase delays gastric emptying of solid meals. J Pharmacol Exp Ther 271: 660 -670, 1994
16. Achem-Karam SR, Funakoshi A, Vinik AI, Owyang C: Plasma motilin concentration and interdigestive migrating motor complex in diabetic gastroparesis: effect of metoclopramide. Gastroenterology 88:492-499, 1985
17. Beales IL, Calam J: Regulation of amylin release from cultured rabbit gastric fundic mucosal cells. BMC Physiol 3:13, 2003
18. Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M, FujimiyaM: Ghrelininduces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 550:227-240, 2003
19. Ariga H, Imai K, Chen C, Mantyh C, Pap- pas TN, Takahashi T: Does ghrelin explain accelerated gastric emptying in the early stages of diabetes mellitus? Am J Physiol Regul Integr Comp Physiol 294: R1807-R1812, 2008
20. Berthoud HR: Vagal and hormonal gut- brain communication: from satiation to satisfaction. Neurogastroenterol Motil 20 (Suppl. 1):64-72, 2008
21. Cai XJ, Evans ML, Lister CA, Leslie RA, Arch JR, Wilson S, Williams G: Hypogly- cemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feedingand possibly mediated by the nucleus of the solitary tract. Diabetes 50:105-112, 2001
22. Schvarcz E, Palmer M, Aman J, Berne C: Atropine inhibits the increase in gastric emptying during hypoglycemia in humans. Diabetes Care 18:1463-1467, 1995
23. Ishiguchi T, Tada H, Nakagawa K, Yamamura T, Takahashi T: Hyperglyce- mia impairs antro-pyloric coordination and delays gastric emptying in conscious rats. Auton Neurosci 95:112-120, 2002
24. Bertin E, Schneider N, Abdelli N, Wam- pach H, Cadiot G, Loboguerrero A, Leu- tenegger M, Liehn JC, Thiefin G: Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy. Diabetes Metab 27:357-364, 2001
25. Woerle HJ, Albrecht M, Linke R, Zschau S, Neumann C, Nicolaus M, Gerich JE, Goke B, Schirra J: Impaired hyperglyce- mia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide. Diabetes Care 31:2325-2331, 2008
26. Fehmann HC, Weber V, Goke R, Goke B, Arnold R: Cosecretion of amylin and insulin from isolated rat pancreas. FEBS Lett 262:279-281, 1990
27. Young A: Unrrsponsiveness in gastric emptying contributes to postprandial hy- perglycemia in type 1 diabetes. Inhibition : of gastric emptying. Adv Pharmacol 52:c 99-121,2005
28. Schmitz O, Brock B, Rungby J: Amylin 5 agonists: a novel approach in the treat, ment of diabetes. Diabetes 53 (Suppl 3):- S233-S238, 2004
29. 29.Ludvik B: [Amylin/IAPP (islet amyloids polypeptide)-physiology and clinical significance]. Wien Klin Wochenschr 109:- 379 -383, 1997
30. 30.Samsom M, Szarka LA, Camilleri M, Vella c A, Zinsmeister AR, Rizza RA: Pramlintide, 2 an amylin analog, selectively delays gastric emptying: potential role of vagal inhi-, bition. Am J Physiol astrointest Liver Physiol 278:G946 -G951, 2000 u 31. Woerle HJ, Mariuz PR, Meyer C, Reich, man RC, Popa EM, Dostou JM, Welle SL, Gerich JE: Mechanisms for the deteriora- n tion in glucose tolerance associated with HIV protease inhibitor regimens. Diabetes e 52:918 -925, 2003
31. le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA, Bloom SR: Postpran-dial plasma ghrelin is suppressed proportional to meal calorie content in normal- weight but not obese subjects. J Clin Endocrinol Metab 90:1068 -1071, 2005 33. Schirra J, Leicht P, Hildebrand P, Beg- linger C, Arnold R, Goke B, Katschinski M: Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide- 1(7-36)amide in non-insulin dependent diabetes mellitus. J Endocrinol 156:177-186, 1998
32. Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R, Goke B: Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97:92-103, 1996
33. Vollmer K, HolstJJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ: Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 57:678-687, 2008
34. Kong MF, King P, Macdonald IA, Black- shaw PE, Perkins AC, Armstrong E, Buchanan KD, Tattersall RB: Effect of eu- glycaemic hyperinsulinaemia on gastric emptying and gastrointestinal hormone responses in normal subjects. Diabetologia 41:474-481, 1998
35. Ahmad SR, Swann J: Exenatide and rare adverse events. N Engl J Med 358:1970-1971, 2008